Cargando…

The Use of Endometrial Cancer Patient–Derived Organoid Culture for Drug Sensitivity Testing Is Feasible

OBJECTIVE: Patient-derived organoids (PDOs), used in multiple tumor types, have allowed evaluation of tumor characteristics from individual patients. This study aimed to assess the feasibility of applying PDO in vitro culture for endocrine-based and drug sensitivity testing in endometrial cancer. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Girda, Eugenia, Huang, Eric C., Leiserowitz, Gary S., Smith, Lloyd H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Uterine Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627540/ https://www.ncbi.nlm.nih.gov/pubmed/28683005 http://dx.doi.org/10.1097/IGC.0000000000001061

Ejemplares similares

Prior Tubal Ligation Might Influence Metastatic Spread of Nonendometrioid Endometrial Carcinoma
por: Li, Mingxia, et al.
Publicado: (2016)

Increased Association Between Endometriosis and Endometrial Cancer: A Nationwide Population-Based Retrospective Cohort Study
por: Yu, Hann-Chin, et al.
Publicado: (2015)

Preoperative Tumor Size at MRI Predicts Deep Myometrial Invasion, Lymph Node Metastases, and Patient Outcome in Endometrial Carcinomas
por: Ytre-Hauge, Sigmund, et al.
Publicado: (2015)

Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?
por: Lan, Chunyan, et al.
Publicado: (2015)

Possible Risk Factors of Pulmonary Metastases in Patients With International Federation of Gynecology and Obstetrics Stage I Endometrioid-Type Endometrial Cancer
por: Jiang, Wei, et al.
Publicado: (2017)

Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model
por: Taurin, Sebastien, et al.
Publicado: (2018)

Efficacy and Safety of AEZS-108 (LHRH Agonist Linked to Doxorubicin) in Women With Advanced or Recurrent Endometrial Cancer Expressing LHRH Receptors: A Multicenter Phase 2 Trial (AGO-GYN5)
por: Emons, Günter, et al.
Publicado: (2014)

Comparison of Survival Benefits of Combined Chemotherapy and Radiotherapy Versus Chemotherapy Alone for Uterine Serous Carcinoma: A Meta-analysis
por: Lin, Yanying, et al.
Publicado: (2017)

Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma
por: Wang, Fangfang, et al.
Publicado: (2017)

Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing
por: Bi, Jianling, et al.
Publicado: (2021)

Patient-derived bladder cancer organoid model to predict sensitivity and feasibility of tailored precision therapy
por: Jiang, Ying, et al.
Publicado: (2023)

Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening
por: Verissimo, Carla S, et al.
Publicado: (2016)

Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids
por: Pinto, Giulia, et al.
Publicado: (2021)

Vaginal mucositis related to immunotherapy in endometrial cancer
por: Patel, Jharna M., et al.
Publicado: (2021)

Lipid profiling of mouse intestinal organoids for studying APC mutations
por: Jukes, Zoë, et al.
Publicado: (2021)

Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer—A National Cancer Database Study
por: Leiserowitz, Gary S., et al.
Publicado: (2017)

Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas
por: Papp, Emoke, et al.
Publicado: (2020)

Establishing patient-derived organoids from human endometrial cancer and normal endometrium
por: Katcher, Arielle, et al.
Publicado: (2023)

Fibroids and Infertility
por: Purohit, P., et al.
Publicado: (2016)

The Role of Complementary and Alternative Medicine for the Management of Fibroids and Associated Symptomatology
por: Dalton-Brewer, Nick
Publicado: (2016)

Natural History of Uterine Fibroids: A Radiological Perspective
por: Ghosh, Srirupa, et al.
Publicado: (2018)

Preclinical testing of oncolytic adenovirus sensitivity in patient-derived tumor organoids
por: Pascual-Sabater, Silvia, et al.
Publicado: (2021)

From cup to dish: how to make and use endometrial organoid and stromal cultures derived from menstrual fluid
por: Hewitt, Sylvia C., et al.
Publicado: (2023)

The histological type of endometrial cancer is not associated with menopause status at diagnosis
por: Sun, Xinyi, et al.
Publicado: (2022)

Culture and differentiation of rabbit intestinal organoids and organoid-derived cell monolayers
por: Kardia, Egi, et al.
Publicado: (2021)

Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing
por: Psilopatis, Iason, et al.
Publicado: (2022)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer
por: Liu, Wenli, et al.
Publicado: (2021)

Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer
por: Lheureux, Stephanie, et al.
Publicado: (2022)

Sensitivity of cervical cytology in endometrial cancer detection in a tertiary hospital in Spain
por: Frias‐Gomez, Jon, et al.
Publicado: (2021)

Investigation of infertility using endometrial organoids
por: Nikolakopoulou, Konstantina, et al.
Publicado: (2021)

Progesterone Signaling in Endometrial Epithelial Organoids
por: Hewitt, Sylvia C., et al.
Publicado: (2022)

In search for biomarkers and potential drug targets for uterine serous endometrial cancer
por: Dinoi, Giorgia, et al.
Publicado: (2021)

MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer
por: Fan, Xingchen, et al.
Publicado: (2021)

Feasibility and utility of MRI and dynamic (18)F-FDG-PET in an orthotopic organoid-based patient-derived mouse model of endometrial cancer
por: Espedal, Heidi, et al.
Publicado: (2021)

Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing
por: Nanki, Yoshiko, et al.
Publicado: (2020)

The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer
por: Huddleston, Adam, et al.
Publicado: (2015)

Drug screening and grouping by sensitivity with a panel of primary cultured cancer spheroids derived from endometrial cancer
por: Kiyohara, Yumiko, et al.
Publicado: (2016)

High-grade serous ovarian carcinoma organoids as models of chromosomal instability
por: Vias, Maria, et al.
Publicado: (2023)

Human Primary Liver Cancer -derived Organoid Cultures for disease modelling and drug screening
por: Broutier, Laura, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_heo2irh71n873setiabd9tt1kv